186 related articles for article (PubMed ID: 24249965)
1. Validation study to compare effects of processing protocols on measured N (ε)-(carboxymethyl)lysine and N (ε)-(carboxyethyl)lysine in blood.
Hull GL; Woodside JV; Ames JM; Cuskelly GJ
J Clin Biochem Nutr; 2013 Nov; 53(3):129-33. PubMed ID: 24249965
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of N
Gong RZ; Wang YH; Wang YF; Chen B; Gao K; Sun YS
Molecules; 2018 Dec; 23(12):. PubMed ID: 30558131
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of N(ε) -(carboxymethyl)Lysine and N(ε) -(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate.
Zhou Y; Lin Q; Jin C; Cheng L; Zheng X; Dai M; Zhang Y
J Food Sci; 2015 Feb; 80(2):C207-17. PubMed ID: 25559609
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
Teerlink T; Barto R; Ten Brink HJ; Schalkwijk CG
Clin Chem; 2004 Jul; 50(7):1222-8. PubMed ID: 15131022
[TBL] [Abstract][Full Text] [Related]
5. Effects of raw meat and process procedure on N
Yu L; Gao C; Zeng M; He Z; Wang L; Zhang S; Chen J
Food Sci Biotechnol; 2016; 25(4):1163-1168. PubMed ID: 30263389
[TBL] [Abstract][Full Text] [Related]
6. N
Jiao Y; He J; Li F; Tao G; Zhang S; Zhang S; Qin F; Zeng M; Chen J
Food Chem; 2017 Oct; 232():683-688. PubMed ID: 28490128
[TBL] [Abstract][Full Text] [Related]
7. N
Yu L; Li Y; Gao C; Yang Y; Zeng M; Chen J
Food Res Int; 2022 May; 155():111048. PubMed ID: 35400433
[TBL] [Abstract][Full Text] [Related]
8. Free L-Lysine and Its Methyl Ester React with Glyoxal and Methylglyoxal in Phosphate Buffer (100 mM, pH 7.4) to Form
Baskal S; Tsikas D
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408807
[TBL] [Abstract][Full Text] [Related]
9. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
10. Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
Engelen L; Persson F; Ferreira I; Rossing P; Hovind P; Teerlink T; Stehouwer CD; Parving HH; Schalkwijk CG
Nephrol Dial Transplant; 2011 Nov; 26(11):3573-7. PubMed ID: 21385863
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Lieuw-A-Fa ML; van Hinsbergh VW; Teerlink T; Barto R; Twisk J; Stehouwer CD; Schalkwijk CG
Nephrol Dial Transplant; 2004 Mar; 19(3):631-6. PubMed ID: 14767019
[TBL] [Abstract][Full Text] [Related]
12. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
[TBL] [Abstract][Full Text] [Related]
13. Formation of N
Jiao Y; He J; He Z; Gao D; Qin F; Xie M; Zeng M; Chen J
Food Res Int; 2019 Jul; 121():738-745. PubMed ID: 31108804
[TBL] [Abstract][Full Text] [Related]
14. Formation of
Zhou P; Dong S; Zeng M
Front Nutr; 2022; 9():883789. PubMed ID: 35495934
[TBL] [Abstract][Full Text] [Related]
15. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
16. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
[TBL] [Abstract][Full Text] [Related]
17. Quantifying carboxymethyl lysine and carboxyethyl lysine in human plasma: clinical insights into aging research using liquid chromatography-tandem mass spectrometry.
Wang D; Wang J; Liu X; Du K; Liu H; Yang X; Liu T; Liu Q; Wang M; Guo J
BMC Biotechnol; 2024 Mar; 24(1):12. PubMed ID: 38454400
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Hanssen NM; Engelen L; Ferreira I; Scheijen JL; Huijberts MS; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1369-73. PubMed ID: 23780372
[TBL] [Abstract][Full Text] [Related]
20. Isotope dilution ESI-LC-MS/MS for quantification of free and total Nε-(1-Carboxymethyl)-L-Lysine and free Nε-(1-Carboxyethyl)-L-Lysine: comparison of total Nε-(1-Carboxymethyl)-L-Lysine levels measured with new method to ELISA assay in gruel samples.
Tareke E; Forslund A; Lindh CH; Fahlgren C; Östman E
Food Chem; 2013 Dec; 141(4):4253-9. PubMed ID: 23993613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]